Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Colombo

Showing results (271-280 of 289) with videos related to

Pageof 29
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid CancerYubing Tao, Fei Wang, Xiaopei Shen, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2013
Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosisRossana G Iannitti, Andrea Casagrande, Antonella De Luca, et al.
American Journal of Respiratory Cell and Molecular Biology|October 17, 2022
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic FibrosisMarilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
Nature Communications|March 15, 2016
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosisRossana G Iannitti, Valerio Napolioni, Vasilis Oikonomou, et al.
Nature Communications|January 17, 2017
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosisSilvia Moretti, Giorgia Renga, Vasilis Oikonomou, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2017
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid CancerFei Wang, Xiaolong Yu, Xiaopei Shen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 12, 2026
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis populationJulie Semenchuk, Yumi Naito, Susan C Charman, et al.
The Lancet. Oncology|October 2, 2025
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort studyMingzhao Xing, Shuhuang Lin, Aarti Mathur, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2020
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational studyRobert Bain, Rebecca Cosgriff, Marco Zampoli, et al.
Infection|December 7, 2021
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis SocietyCarla Colombo, Marco Cipolli, Valeria Daccò, et al.
Pageof 29

Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid CancerYubing Tao, Fei Wang, Xiaopei Shen, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2013
Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosisRossana G Iannitti, Andrea Casagrande, Antonella De Luca, et al.
American Journal of Respiratory Cell and Molecular Biology|October 17, 2022
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic FibrosisMarilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
Nature Communications|March 15, 2016
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosisRossana G Iannitti, Valerio Napolioni, Vasilis Oikonomou, et al.
Nature Communications|January 17, 2017
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosisSilvia Moretti, Giorgia Renga, Vasilis Oikonomou, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2017
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid CancerFei Wang, Xiaolong Yu, Xiaopei Shen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 12, 2026
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis populationJulie Semenchuk, Yumi Naito, Susan C Charman, et al.
The Lancet. Oncology|October 2, 2025
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort studyMingzhao Xing, Shuhuang Lin, Aarti Mathur, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2020
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational studyRobert Bain, Rebecca Cosgriff, Marco Zampoli, et al.
Infection|December 7, 2021
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis SocietyCarla Colombo, Marco Cipolli, Valeria Daccò, et al.
Pageof 29